4.7 Article

Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 106, Issue 6, Pages 1576-1584

Publisher

ENDOCRINE SOC
DOI: 10.1210/clinem/dgab147

Keywords

LDL cholesterol; insulin secretion; type 2 diabetes; glucagon; insulin clearance

Funding

  1. Federal Ministry of Education and Research (BMBF) [01GI0925]

Ask authors/readers for more resources

This study found no association between LDL cholesterol and glucagon levels, but significant positive associations with C-peptide-based indices of insulin secretion, and negative associations with insulin-based secretion indices. LDL cholesterol levels were also positively associated with insulin clearance, both in the fasting state and post-glucose load.
Context: Pharmacological lowering of low-density lipoprotein (LDL) cholesterol potently reduces cardiovascular risk while concurrently increasing type 2 diabetes risk. Objective: The aim of this study was to investigate the relationship between LDL cholesterol concentrations and insulin secretion and glucagon levels. Methods: A total of 3039 individuals without cholesterol-lowering therapy, but with increased risk for diabetes, underwent routine blood tests and a 5-point oral glucose tolerance test (OGTT). Glucagon concentrations, insulin secretion, and insulin clearance indices were derived from the OGTT. Results: There was no association between LDL cholesterol and fasting glucagon (P =.7, beta = -.01) or post-glucose load glucagon levels (P =.7, beta = -.07), but we detected significant positive associations of LDL cholesterol and C-peptide-based indices of insulin secretion (area under the curve [AUC](C-Peptide(0-30min)/)AUC(Glucose(0-30min)): P <.001, beta =.06; AUC(C-Peptide(0-120min)) /AUC(Glucose(0-120min)): P <.001, beta = -.08). In contrast, we found a negative association of insulin-based insulin secretion indices with LDL concentrations (insulinogenic index: P =.01, beta = -.04; disposition index: P <.001, beta = -.06). LDL cholesterol levels, however, were positively associated with insulin clearance assessed from C-peptide and insulin concentrations, both in the fasting state and post-glucose load (P <.001, beta =.09 and P <.001, beta =.06, respectively). Conclusion: As C-peptide based indices reflect insulin secretion independent of hepatic clearance, our results indicate lower insulin secretion in case of lesser LDL cholesterol. This could explain deteriorating glycemic control in response to cholesterol-lowering drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available